NCT06398717

Brief Summary

Pain after anterior cruciate ligament reconstruction with autologous hamstring graft can be attributed to both arthroscopic surgery and the graft donor site. Many methods are available to provide postoperative analgesia for patients undergoing total knee arthroplasty, but it is unclear how they compare with each other. The extent to which the two techniques anterior division obturator nerve block vs peritendinous hamstring injection may benefit the patients in terms of overall analgesia and specifically the autograft site analgesia needs evaluation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

May 3, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

April 24, 2024

Last Update Submit

May 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • post operative pain control

    The postoperative visual analogue scale pain score.( from 0 to 10, 0 being "no pain" and 10 being "worst possible pain." )

    6 hours

Secondary Outcomes (6)

  • pain controlling methods

    24 hours

  • pain controlling methods

    24 hours

  • pain controlling methods

    24 hours

  • pain controlling methods

    24 hours

  • pain controlling methods

    24 hours

  • +1 more secondary outcomes

Study Arms (3)

group C: will receive unilateral adductor canal block alone

ACTIVE COMPARATOR
Procedure: adductor canal block

group H:will receive unilateral peri-hamstring injection combined to adductor canal block

ACTIVE COMPARATOR
Procedure: adductor canal block

group O: will receive unilateral anterior obturator nerve block combined to adductor canal block

ACTIVE COMPARATOR
Procedure: adductor canal block

Interventions

group C will receive a unilateral adductor canal block alone, using an ultrasound to identify the location of the nerve. group H will receive unilateral peri-hamstring injection combined to adductor canal block, After the adductor canal block, the transducer will be moved posteriorly till identifying the site of injection group O will receive unilateral anterior obturator nerve block combined with adductor canal block, The anterior branch of the obturator nerve is located using ultrasound

Also known as: obturator canal block, peri-hamestring injection
group C: will receive unilateral adductor canal block alonegroup H:will receive unilateral peri-hamstring injection combined to adductor canal blockgroup O: will receive unilateral anterior obturator nerve block combined to adductor canal block

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 21-70 years
  • Both sex
  • Patients scheduled for elective arthroscopic anterior cruciate ligament reconstruction under general anesthesia.
  • American Society of Anesthesiologists Physical Status Class I, II Patients.
  • Body Mass Index \<30 kg/m2.

You may not qualify if:

  • History of allergy to the study medications.
  • American Society of Anesthesiologists class ≥III.
  • Patients refusal to participate in the study.
  • The inability to comprehend or participate in the pain scoring system.
  • Contraindications to regional anesthesia (including coagulopathy and local infection).
  • Psychiatric disorder and patient with any neurological disorder.
  • Opioid tolerance or dependence.
  • Distorted anatomy.
  • Peripheral neuropathy.
  • Renal or hepatic impairment.
  • Morbid obesity (Body Mass Index: \>30kg/m2).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Mohamed Ibrahim El-Desoukey, Master degree

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

April 24, 2024

First Posted

May 3, 2024

Study Start

May 1, 2024

Primary Completion

November 1, 2024

Study Completion

January 31, 2025

Last Updated

May 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share